Visible Genetics Preparing TruGene HIV Genotyping Assay FDA Submission
This article was originally published in The Gray Sheet
Executive Summary
Visible Genetics, Inc. is looking to file an FDA application for its TruGene HIV genotyping assay kit in the first half of 2000, the company reported Nov. 30 at a BancBoston Robertson Stephens health care conference in New York City.